Dr. Scott Mitchell Lieberman, MD

Dr. Lieberman practices at Pulmonary Physicians of South Florida in Miami, Florida.

Dr. Lieberman's NPI, 1134412760, was assigned on May 16, 2011. Dr. Lieberman graduated from St. George's University School of Medicine in 2011. Dr. Lieberman holds Florida license ME122868.

Dr. Lieberman's primary practice is Pulmonary Physicians of South Florida, at 8600 Sw 92nd St, Miami, FL 33156 in Miami-Dade County. The practice phone is (305) 436-9933.

Dr. Lieberman's primary practice is Pulmonary Physicians of South Florida in Miami, Florida. Dr. Lieberman is also affiliated with Broward Health Coral Springs. The medical group on file is Pulmonary Physicians of South Florida. Dmand AI also links Dr. Lieberman to 4 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lieberman practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Lieberman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Lieberman is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lieberman's licenses on file in 8 states: Florida, New Hampshire, Tennessee, Indiana, Arkansas, Georgia, New Mexico and West Virginia.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), hypersomnia, pneumonia, pulmonary fibrosis, pulmonary heart disease, sleep apnea and tobacco use among the conditions Dr. Lieberman treats.

CMS data shows 3,394 Medicare services from Dr. Lieberman across 10 procedure codes in 2024, for 698 Medicare patients. Medicare paid $267,505 for them.

CMS counts 698 Medicare patients who saw Dr. Lieberman in 2024. The largest group is 75 to 84, with 282 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lieberman's median patient age at 70, with 56% women.

In 2024, Dr. Lieberman wrote 1,045 Medicare Part D claims for 215 patients. 29% of them were for generic drugs. CMS names the drug for 907 of them, across 16 drugs with 11 or more claims each, at $268,450 in total drug cost. In 2023, CMS named 770 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 69 out of 100 for Dr. Lieberman for performance year 2024, reported individually. Dr. Lieberman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 19 papers to Dr. Lieberman, published from 2012 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Inflammation, Mice, Inbred NOD and Mice, Knockout. Dr. Lieberman has published most often in Int J Mol Sci. Dr. Lieberman's most frequent co-authors are Scott Lieberman, MD, PhD, Edward Malachi Behrens, MD and Ruth Fernandez Ruiz, MD.

Dmand AI links Dr. Lieberman to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Negative rheumatoid factor polyarthritis and Arthritis, Juvenile.

CMS Open Payments shows 152 general payments to Dr. Lieberman from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. GlaxoSmithKline, LLC. paid the most, $972.

Dr. Lieberman graduated from St. George's University School of Medicine in 2011.

Dr. Lieberman is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.